Cell-free Biosensor for the Detection of Pathogens

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$100,000.00
Award Year:
2005
Program:
SBIR
Phase:
Phase I
Contract:
1R43AI063693-01
Award Id:
75950
Agency Tracking Number:
AI063693
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Integral Molecular, 3701 Market St, Ste 340, Philadelphia, PA, 19104
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
BENJAMINDORANZ
(215) 966-6018
bdoranz@integralmolecular.com
Business Contact:
BENJAMINDORANZ
(215) 966-6018
BDORANZ@INTEGRALMOLECULAR.COM
Research Institute:
n/a
Abstract
DESCRIPTION (provided by applicant): Biosensors capable of detecting infectious agents, and/or of detecting a serological reaction in people potentially exposed to dangerous pathogens, are fundamental to rapid biodefense screening and response processes. Biosensors based on the signaling properties of membrane proteins in living cells are being increasingly developed and used to detect pathogens, but are limited by the stringent handling requirements of living cells. The ability to retain membrane proteins in their native structure within a cell-free environment could enable new types of bio-mimetic detectors to be created that exploit the cell's natural detection mechanisms but without the inherent limitations of living cell assays. The need for novel detection methods that can detect antibody responses to pathogens and, in a revised format, biodefense pathogens themselves, is exemplified by Dengue virus (DEN), a category A biodefense pathogen that results in 100 million cases of DEN related illness annually. DEN exists as four major serotypes, and their distinction is important because sequential exposure to different serotypes increases the likelihood of developing dengue hemorrhagic fever. For such pathogens, characterizing not only the magnitude, but also the breadth, persistence, and specificity of the humoral response is an important component of evaluating candidate vaccines, and understanding pathogenesis in infected individuals. Thus, in addition to biodefense detection, the availability of a rapid, in-field sensor that can detect antibodies against such pathogens could aid in the development and administration of vaccines in endemic regions. The commercial product that will result from this proposal will be a nanometer-scale, cell-free assay system for the detection of pathogen antigens and antibodies present in biological or environmental samples.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government